Sympatholysis in Chronic Kidney Disease
This study is looking into why people with chronic kidney disease (CKD) have trouble exercising and experience increased blood pressure during physical activity. Researchers want to understand if problems with blood vessel widening or narrowing play a role. You might be eligible if you are a veteran aged 18-75 with Stage III or IV CKD, a kidney transplant recipient, or a veteran without kidney disease who exercises less than twice a week. The study is testing if taking Sodium Bicarbonate tablets or a placebo (an inactive pill) before exercise or stretching can help. The main goals are to see how these interventions affect muscle oxygen, muscle pH (acidity), and blood vessel narrowing after 12 weeks. The current status of the study is unclear, and it plans to enroll 110 participants.
- Study design
- This is an interventional study that plans to enroll 110 participants. It compares different interventions like Sodium Bicarbonate, placebo, exercise training, and stretching.
- What's involved
- Participants will take Sodium Bicarbonate or a placebo before exercise or stretching sessions, 3 times per week for 6-12 weeks. Serum bicarbonate levels will be monitored regularly.
- Compensation
- Not stated in the trial record.
- Follow-up
- Changes in muscle oxygenation, muscle pH, and venoconstriction will be measured at 12 weeks after the start of the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Sympatholysis in Chronic Kidney Disease
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jeanie Park, MD · PRINCIPAL_INVESTIGATOR · Emory University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in muscle oxygenation after exercise/stretching trainingBaseline, Week 12
Near-infrared spectroscopy (NIRS) will measure and record tissue oxyhemoglobin, deoxyhemoglobin, and total hemoglobin.
- Change in muscle interstitial pH after exercise/stretching trainingBaseline, Week 12
Near-infrared spectroscopy (NIRS) will give an estimation of the pH levels within the muscle interstitial space. Muscle interstitial pH markedly decreases during exercise, and is often lower than blood pH with a larger intracellular to interstitial pH gradient. CKD patients may have less ability to buffer pH changes in the interstitial space during exercise. Bicarbonate supplementation may improve muscle interstitial buffering capacity during exercise, and prevent exaggerated reductions in muscle interstitial pH during exercise.
- Change in venoconstriction after exercise/stretching trainingBaseline, Week 12
Dorsal hand vein model will be used to assess vascular alpha-1 adrenergic responsiveness by measuring the degree of venous constriction in response to varying dosages of local phenylephrine (PE) infusion.